How Angels Are Different From VCs

Hello, this is Hall T. Martin with the Startup Funding Espresso -- your daily shot of startup funding and investing.

Both angels and venture capitalists invest in early-stage companies.

Here are the key differences between the two:

Angels invest their own money while VCs invest other people's money.

This makes the angel investor more risk-averse, while the VC often takes bigger risks.

Most angels hold down a day job while most VCs are full-time in that role.

Angels don't get paid to invest while VCs charge a management fee on the funds they deploy.

Angels typically invest small amounts on their own unless they gather into groups and make a joint investment.

VCs employ larger sums of money because they collected funds from many Limited Partners during their own fundraise.

Most VCs lead the round if there isn't one, while most angel investors join party rounds rather than lead the deal, as it takes a great amount of time.

Angel groups can bring some of the angel investors closer to some of the benefits of the venture capitalist.

In pitching angels and VCs, keep these points in mind.

Thank you for joining us for the Startup Funding Espresso where we help startups and investors connect for funding.

Let's go startup something today.

_________________________________________________________

For more episodes from Investor Connect, please visit the site at: http://investorconnect.org

Check out our other podcasts here: https://investorconnect.org/
For Investors check out: https://tencapital.group/investor-landing/
For Startups check out: https://tencapital.group/company-landing/
For eGuides check out: https://tencapital.group/education/
For upcoming Events, check out https://tencapital.group/events/

For Feedback please contact info@tencapital.group

Please follow, share, and leave a review.

Music courtesy of Bensound.

Gaining Sales Traction for Fundraising

Hello, this is Hall T. Martin with the Startup Funding Espresso -- your daily shot of startup funding and investing.

In raising funding, revenue traction is a key driver in attracting investors.

Here are some key steps to gain sales traction for your fundraise.

Early-stage companies don't have a large number of users, as that will take time.

Instead, start with a small but dedicated set of users.

Engagement with the product comes before revenue.

Bring a strong story of initial users engaging with the product.

Show how they are daily, weekly, and monthly active users.

Calculate a customer ROI for the initial cohort of users and share that number with the investors.

Large numbers of users who rarely use the product will fail to convince investors.

A small group of users who can't live without the product will attract investors.

Show how customer acquisition is a repeatable and predictable process.

This shows the investor that you can increase sales as needed.

Consider these steps in gaining sales traction for fundraising.

Thank you for joining us for the Startup Funding Espresso where we help startups and investors connect for funding.

Let's go startup something today.

_________________________________________________________

For more episodes from Investor Connect, please visit the site at: http://investorconnect.org

Check out our other podcasts here: https://investorconnect.org/
For Investors check out: https://tencapital.group/investor-landing/
For Startups check out: https://tencapital.group/company-landing/
For eGuides check out: https://tencapital.group/education/
For upcoming Events, check out https://tencapital.group/events/

For Feedback please contact info@tencapital.group

Please follow, share, and leave a review.

Music courtesy of Bensound.

In this episode of Investor Connect, we hear from Dr. Swarna Balasubramaniam, a surgeon-turned-founder, who presents Noleus Leaf, a perioperative therapeutic device designed to restart bowel function and shorten the long, complication-prone recovery after major abdominal surgery, where patients often remain hospitalized 2 to 14 days waiting for intestines to "wake up."

She explains how excess IV fluids swell the intestines, contributing to ileus, and how Noleus Leaf uses negative pressure (vacuum) therapy placed at the end of surgery for six hours and then removed at the bedside to remove fluid and help patients eat and drink sooner, supporting healing. Dr. Balasubramaniam shares first-in-human study results conducted outside the US showing patients tolerated internal negative pressure therapy and bedside removal, and recovered bowel function two days earlier than supportive care. She outlines the market opportunity, citing about 2.9 million patients affected, additional use cases in inflammatory or infectious GI conditions, and economics including a device cost under $300 at scale and potential pricing tied to saving roughly two hospital days.

The discussion also covers regulatory and commercialization plans, including pursuing a 510(k) pathway leveraging negative pressure wound therapy predicates rather than a De Novo approach, targeting large tertiary and quaternary surgical centers first, and building a sales motion that requires both surgeon champions and hospital value analysis approval. Dr. Balas notes the company has been capital efficient (under $4 million to date), is raising $1.4 million to support a 10–15 patient trial and verification/validation work for FDA clearance, and anticipates commercialization in about two and a half years, with potential exit paths to large medical device or wound care companies.

________________________________________________________________________

For more episodes from Investor Connect, please visit the site at: http://investorconnect.org

Check out our other podcasts here: https://investorconnect.org/
For Investors check out: https://tencapital.group/investor-landing/
For Startups check out: https://tencapital.group/company-landing/
For eGuides check out: https:/_/tencapital.group/education/
For upcoming Events, check out https://tencapital.group/events/

For Feedback please contact info@tencapital.group

Please follow, share, and leave a review.

Music courtesy of Bensound.